Mutations in β-2 microglobulin of tumor surface antigens may lead to the loss of human leukocyte antigen, impairing the effective presentation of tumor antigens on the surface of tumor cells and thereby reducing the recognition function of CD8+ T cell (27). Here, CD8A is linked to neoplasm.